Latest stories on MDGL
Madrigal Pharmaceuticals: The Market Is Grading A Launch, Not A Self-Funding Franchise
Seeking Alpha64 · neutralgeneral
Madrigal Pharmaceuticals to Release Third-Quarter 2026 Financial Results and Host Webcast on November 3, 2026
Business Insider50 · neutralgeneral
Madrigal Pharmaceuticals to Release Third-Quarter 2026 Financial Results and Host Webcast on November 3, 2026
GlobeNewswire50 · neutralgeneral
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Business Insider52 · neutralgeneral
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire52 · neutralgeneral
UBS raises Madrigal Pharmaceuticals stock price target on F4 trial outlook
Investing.com Analyst Ratings64 · neutralanalyst
Madrigal Pharmaceuticals price target raised to $735 from $669 at UBS
The Fly64 · neutralanalyst
Madrigal Pharmaceuticals resumed with a Buy at Goldman Sachs
The Fly61 · neutralanalyst
Madrigal Pharmaceuticals initiated with a Buy at Citi
The Fly61 · neutralanalyst
Madrigal Pharmaceuticals management to meet with Oppenheimer
The Fly50 · neutralgeneral
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Madrigal Pharmaceuticals, Inc. (MDGL) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
Seeking Alpha56 · neutralproduct/pr
Institutional Investors Are Loading Up on Madrigal Pharmaceuticals Stock. Should You?
Yahoo Top63 · neutralgeneral
Institutional Investors Are Loading Up on Madrigal Pharmaceuticals Stock. Should You?
The Motley Fool63 · neutralgeneral
Madrigal Pharmaceuticals to Participate in the 2026 Cantor Global Healthcare Conference
StockTitan55 · neutralgeneral
Here's Exactly What It Will Take for Madrigal Pharmaceuticals Stock to Take Off
The Motley Fool57 · neutralgeneral
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Madrigal Pharmaceuticals Adds Renowned Leader to Board
TipRanks65 · bullishgeneral
MADRIGAL PHARMACEUTICALS, INC. (MDGL) files 8-K
SEC 8-K50 · neutralgeneral
Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors
Business Insider55 · neutralgeneral